CRO support for ncats medicinal chemistry for lead optimization.

Ended Awarded Last action

Contract number
75N95019D00032
Awardee
Awarding agency
Task orders
2 $1,825,492 obligated

Award facts

Opportunity
Combined order value
  • $1,825,492 Current, with exercised options
  • $3,675,416 Potential, with all options
Last date to order 100% complete
IDV ceiling 10% used
$17,887,012.00
Maximum order
$17,887,012.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 13 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) valued up to $17,887,012 to Organix Chemistry Solutions LLC for CRO Support for NCATS Medicinal Chemistry for Lead Optimization. Under this multiple-award IDC, Organix was issued two delivery orders to date.

The first delivery order, valued at $3,677,412.09, provides synthetic chemistry support services to NCATS' Therapeutics Development Branch Medicinal Chemistry Team over a two-year period from September 2020 to September 2022. The second delivery order, valued at $1,000, was for a contract kickoff conference call to support medicinal chemistry for lead optimization activities. Both delivery orders are performed on a cost-no-fee basis at Organix's facility in Woburn, Massachusetts. This IDC and associated task orders aim to support NCATS' medicinal chemistry research efforts to advance preclinical candidate optimization and development.

Task orders

Transactions

Action Obligated Date
Terminate for Convenience P00003 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI notice of termination for convenience. CRO… $0
Supplemental Agreement for work within scope P00001 $0
Other Administrative Action P00002 $0
Original award $0

Quick answers

Who was awarded contract 75N95019D00032?

75N95019D00032 was awarded to Organix Chemistry Solutions LLC by National Institute on Drug Abuse (National Institutes of Health) on September 26, 2019.

How much is contract 75N95019D00032 worth?

Orders under 75N95019D00032 have obligated $1,825,492. Their combined potential value, with all options, is $3,675,416. 75N95019D00032's own ceiling is $17,887,012. A single order can be worth up to $17,887,012.

How many orders have been placed under contract 75N95019D00032?

2 orders have been placed under 75N95019D00032, the latest on September 28, 2020.

Which agency awarded contract 75N95019D00032?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019D00032, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Who can order from contract 75N95019D00032?

75N95019D00032 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N95019D00032 part of a contract vehicle?

Yes. 75N95019D00032 is part of CRO Support for NCATS Medicinal Chemistry for Lead Optimization.

Was contract 75N95019D00032 competed?

The extent of competition for 75N95019D00032 was full and open competition. The government received 13 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV